No video

Pathogenesis and Treatment of Hepatic Fibrosis: Is reversal of Cirrhosis a Myth? by Meena Bansal, MD

  Рет қаралды 14,743

INEDSYS Library

INEDSYS Library

Күн бұрын

Dr. Bansal is currently Professor of Medicine, Director of the newly formed NASH Center of Excellence, and Director of Translational Research in the Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai. Just recently she served as Secretary for AASLD, Deputy Chief Medical Officer for Mount Sinai Health Partners, and Vice President, Population Health for Quality and Efficiency.
Dr. Bansal attended Harvard University and then Cornell Medical School. She did her internship and residency at Cornell Medical School and then completed Gastroenterology Fellowship at the University of Pennsylvania in 2001.
Dr. Bansal joined the faculty at Mount Sinai in 2001 and from 2002-2009 she served as Transplant Hepatology Fellowship Director, leading one of the largest transplant hepatology fellowships in the United States. While remaining clinically active, she developed an NIH-funded basic research program focusing on understanding underlying molecular mechanisms of liver fibrosis and stellate cell biology in an effort to develop novel anti-fibrotic therapies. Her current research interests focus on the impact of HIV on hepatic inflammation and fibrosis and translational and clinical research in NASH. She has been the principal investigator for numerous clinical trials ranging from HCV to NASH. Over the past 5 years, her focus had also been on building a population health infrastructure that will allow a large academic health system to be successful in value-based care. She recently stepped down from this role to lead the NASH Center of Excellence at the Icahn School of Medicine developing a longitudinal registry, implementing screening and predictive algorithms for the identification of patients with significant fibrosis, creating multidisciplinary clinics, and conducting an array of investigator-initiated NASH translational and clinical studies.
The current talk was delivered at the INEDSYS Hepatology Club on July 23rd, 2022.
Please visit INEDSYS.com to access past talks and don't forget to subscribe freely to
INEDSYS's KZfaq channel using the following link: / @inedsyslibrary

Пікірлер: 17
@tachibanadosetsu4947
@tachibanadosetsu4947 Жыл бұрын
I was diagnosed with cirrhosis based on Fibroscan requested by my gastroenterologist and on december 2021 my score was 15.7kpa, so stage 4 (cirrhosis) which was caused by fatty liver disease, I started the ketogenic diet with intermittent fasting , 1 year, 75 fewer pounds later, yesterday I went for another fibroscan, my score went from 15.7kpa to 4.5kpa, stage 1(mild/no fibrosis) so...YES Cirrhosis IS reversible
@EbhoomanGabriel-tk6ru
@EbhoomanGabriel-tk6ru Жыл бұрын
❤hello everyone I got cured of liver problems and diabetes using herbal remedy from Doctor Oluwa herbal center on KZfaq and within 15 days I was okay Check out Doctor Oluwa herbal center on KZfaq if you are sick or infected , his herbs are 100 percent effective
@ionaworld7034
@ionaworld7034 Жыл бұрын
I dont believe you
@tachibanadosetsu4947
@tachibanadosetsu4947 Жыл бұрын
@@ionaworld7034 you are entitled to your opinion
@rochlabelle5070
@rochlabelle5070 9 ай бұрын
Your fibroscan score was certainly an indication of liver inflammation and possible cirrhosis but the only accepted diagnosis of liver cirrhosis is through a liver biopsy. Congrats on changing your lifestyle and reducing your fibroscan score but the fact you were able to reduce your kpa score from 15.7 to 4.5 in one year is a strong indication that you were dealing with liver inflammation
@user-bl4rz6vh9x
@user-bl4rz6vh9x 7 ай бұрын
I had normal LFTs with Ultrasound showing grade 1 fatty liver, but my fibroscan is 16.4 but my GI told it’s fibrosis and not the cirrosis and it’s reversible with medication, regular exercise and weight loss. Hoping to reverse it or at least make it better in a year. I am on Saroglitazar and Vitamin E
@arindombaidya4951
@arindombaidya4951 Жыл бұрын
Brilliant lecture
@syed_21188
@syed_21188 5 ай бұрын
The problem is that research needs to be done on the various natural supplements out there on cirrhosis. Also we need a study of 3 days and 7 days water fast on cirrhosis. We can't just look at simtuzumab and then call it quits.
@christophegenbrugge6815
@christophegenbrugge6815 3 ай бұрын
What supplements? Serraptase? Milkthistle
@vicguani2108
@vicguani2108 Жыл бұрын
How about boosting gut microbiom
@baysick11
@baysick11 7 ай бұрын
Can Fibroscan be inaccurate? I’ve read also if someone has hemangioma it could “overestimate” fibroscan score?
@muxayoradjabova5064
@muxayoradjabova5064 Жыл бұрын
No andesten
Progression of Liver Disease Webcast Series: Cirrhosis and Signs of Liver Failure
34:27
American Liver Foundation
Рет қаралды 150 М.
The FASTEST Way to Reverse Fatty Liver, Naturally | NAFLD Treatment
13:23
Leonid Kim MD
Рет қаралды 3,5 МЛН
Они так быстро убрались!
01:00
Аришнев
Рет қаралды 3,2 МЛН
Joker can't swim!#joker #shorts
00:46
Untitled Joker
Рет қаралды 39 МЛН
Doing This Instead Of Studying.. 😳
00:12
Jojo Sim
Рет қаралды 36 МЛН
NAFLD and clinical significance of grading fibrosis
8:04
Ashok Jaiswal
Рет қаралды 16 М.
The SURPRISING Way To Reverse A FATTY LIVER | Dr. Mark Hyman
12:04
Mark Hyman, MD
Рет қаралды 1,2 МЛН
NAFLD is now MASLD: What’s New in 2023
58:44
UWDeptMedicine
Рет қаралды 3,5 М.
The BEST 7 Foods to Clean Out Your Liver
20:02
Dr. Eric Berg DC
Рет қаралды 5 МЛН
Autoimmune Hepatitis 101/102: Diagnosis and Treatment Overview
28:56
Autoimmune Hepatitis
Рет қаралды 4 М.
Они так быстро убрались!
01:00
Аришнев
Рет қаралды 3,2 МЛН